Background In the first recruitment phase of a randomized trial of cervical cancer screening
methods (New Technologies for Cervical Cancer Screening [NTCC] study), we compared …

The Canadian Cervical Cancer Screening Trial was a randomized controlled trial comparing
the performance of human papillomavirus (HPV) testing and Papanicolaou cytology to …

Background: Although testing for human papillomavirus (HPV) has higher sensitivity and
lower specificity than cytology alone for detecting cervical intraepithelial neoplasia (CIN) …

Objectives ATHENA evaluated the cobas HPV Test as the primary screen for cervical cancer
in women≥ 25 years. This reports the 3-year end-of-study results comparing the …

Background Primary cervical screening with both human papillomavirus (HPV) DNA testing
and cytological examination of cervical cells with a Pap test (cytology) has been evaluated in …

Several studies suggest that HPV testing is more sensitive than cytology in primary cervical
screening. These studies had different designs and were reported in different ways …

Complete Round 1 data (baseline and 12‐month follow‐up) for HPV FOCAL, a randomized
trial establishing the efficacy of HPV DNA testing with cytology triage as a primary screen for …

Since infection with oncogenic human papillomavirus (HPV) has been considered a
necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as …

Background To determine whether testing for DNA of oncogenic human papillomaviruses
(HPV) is superior to the Papanicolaou (Pap) test for cervical-cancer screening, we …

Despite its history of success in cancer screening, Pap cytology has important limitations,
particularly its high false-negative rate, which carries important public health implications …